Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, nominal value of $0.01 per share
-
Shares outstanding
-
2,461,355,158
-
Total 13F shares
-
1,941,513
-
Share change
-
+1,941,513
-
Total reported value
-
$19,803,000
-
Price per share
-
$10.20
-
Number of holders
-
15
-
Value change
-
+$19,803,000
-
Number of buys
-
15
Institutional Holders of Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) as of Q3 2021
As of 30 Sep 2021,
Sofgen Pharma S.A. - Ordinary Shares, nominal value of $0.01 per share (PROCF) was held by
15 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,941,513 shares.
The largest 10 holders included
COMPASS GROUP LLC, BERKLEY W R CORP, Sectoral Asset Management Inc, D. E. Shaw & Co., Inc., Itau Unibanco Holding S.A., HRT FINANCIAL LP, Fort Baker Capital Management LP, CITADEL ADVISORS LLC, Kepos Capital LP, and JPMORGAN CHASE & CO.
This page lists
15
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.